These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24623379)

  • 1. An update on metabolic assessment in patients with urinary lithiasis.
    Amaro CR; Goldberg J; Damasio PC; Leitão VA; Turney B; Padovani CR; Amaro JL
    World J Urol; 2015 Jan; 33(1):125-9. PubMed ID: 24623379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic assessment in patients with urinary lithiasis.
    Amaro CR; Goldberg J; Amaro JL; Padovani CR
    Int Braz J Urol; 2005; 31(1):29-33. PubMed ID: 15763005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic features and renal outcomes of urolithiasis in children.
    Lee ST; Cho H
    Ren Fail; 2016 Jul; 38(6):927-32. PubMed ID: 27098938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and metabolic abnormalities in preschool-age children with urolithiasis in southeast Anatolia.
    Elmacı AM; Ece A; Akın F
    J Pediatr Urol; 2014 Jun; 10(3):495-9. PubMed ID: 24314604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disorders in Turkish children with urolithiasis.
    Celiksoy MH; Yilmaz A; Aydogan G; Kiyak A; Topal E; Sander S
    Urology; 2015 Apr; 85(4):909-13. PubMed ID: 25817115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic evaluation of children with urolithiasis.
    Gouru VR; Pogula VR; Vaddi SP; Manne V; Byram R; Kadiyala LS
    Urol Ann; 2018; 10(1):94-99. PubMed ID: 29416283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
    Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
    Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
    Cicerello E; Mangano M; Cova GD; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2016 Oct; 88(3):208-211. PubMed ID: 27711095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Metabolic Disorders Associated with Urolithiasis in Cuban Pediatric Patients.
    Bacallao-Méndez RA; Mañalich-Comas R; Gutiérrez-García F; Madrid-Mancia CF; Lucero-Méndez C; Smith-González MJ
    MEDICC Rev; 2021 Jan; 23(1):43-48. PubMed ID: 33780422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic factors associated with urinary calculi in children.
    Naseri M; Varasteh AR; Alamdaran SA
    Iran J Kidney Dis; 2010 Jan; 4(1):32-8. PubMed ID: 20081302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric urolithiasis: metabolic risk factors and follow-up results in a Turkish region with endemic stone disease.
    Elmacı AM; Ece A; Akın F
    Urolithiasis; 2014 Oct; 42(5):421-6. PubMed ID: 25022263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Hypocitraturia in Stone Formers from the Maya Region of Yucatan, Mexico.
    Basulto-Martínez M; Peña-Espinoza B; Valdez-Ortiz R; Escalante-Sosa R; Flores-Tapia JP; Menjivar M
    Arch Med Res; 2022 Jan; 53(1):69-78. PubMed ID: 34243991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urolithiasis in the first year of life.
    Güven AG; Koyun M; Baysal YE; Akman S; Alimoglu E; Akbas H; Kabaalioglu A
    Pediatr Nephrol; 2010 Jan; 25(1):129-34. PubMed ID: 19705157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of medical treatment and metabolic risk factors in children with urolithiasis.
    Gürgöze MK; Sarı MY
    Pediatr Nephrol; 2011 Jun; 26(6):933-7. PubMed ID: 21340610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.